Asia
The companies said the collaboration recognizes a “great need for novel treatments in the area of neuropsychiatric medicine development.”
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
The announcement came following independent FDA analyses of inspections conducted at the two CROs in November 2019.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
The news sparked a mini-surge in shares of I-Mab, which were up 7.8% in pre-market U.S trading on September 28.
These life sciences companies are falling into some cold, hard investment cash.
Anji will use the new funds to advance its two late-stage clinical programs in metabolic disorders and propel its oncology pipeline into the clinic.
The analysis showed a 52-week glucose remission rate of 65.2% among the 69 patients being followed.
Aside from the fraud trial of Theranos founder Elizabeth Holmes, other court-related cases are taking place, including between Takeda and AbbVie over cancer drug, Lupron.
There was still some carryover from the European Society of Medical Oncology Congress 2021, but there was plenty of other clinical trial news last week. Here’s a look.
PRESS RELEASES